The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_130839.5(UBE3A):c.618A>T (p.Ala206=)

CA291604

137882 (ClinVar)

Gene: UBE3A
Condition: Angelman syndrome
Inheritance Mode: Autosomal dominant inheritance (with paternal imprinting (HP:0012274))
UUID: 35c28eab-d2ba-41e1-8213-1409e06ebbfe
Approved on: 2022-06-30
Published on: 2022-06-30

HGVS expressions

NM_130839.5:c.618A>T
NM_130839.5(UBE3A):c.618A>T (p.Ala206=)
NC_000015.10:g.25371556T>A
CM000677.2:g.25371556T>A
NC_000015.9:g.25616703T>A
CM000677.1:g.25616703T>A
NC_000015.8:g.23167796T>A
NG_009268.1:g.72426A>T
ENST00000438097.6:c.558A>T
ENST00000625778.3:c.558A>T
ENST00000635914.1:c.558A>T
ENST00000637886.1:c.618A>T
ENST00000638011.1:c.558A>T
ENST00000638155.1:c.558A>T
ENST00000648336.2:c.618A>T
ENST00000649550.1:c.558A>T
ENST00000650110.1:c.627A>T
ENST00000675000.1:n.1293A>T
ENST00000675177.1:c.441A>T
ENST00000675593.1:n.3314A>T
ENST00000232165.7:c.558A>T
ENST00000397954.6:c.627A>T
ENST00000428984.6:c.558A>T
ENST00000438097.5:c.558A>T
ENST00000566215.5:c.558A>T
ENST00000614096.4:c.618A>T
ENST00000625778.2:c.558A>T
ENST00000626068.2:c.639A>T
ENST00000626793.2:n.669A>T
ENST00000630424.2:c.558A>T
NM_000462.3:c.627A>T
NM_130838.1:c.558A>T
NM_130839.2:c.618A>T
NM_000462.5:c.627A>T
NM_001354505.1:c.618A>T
NM_001354506.1:c.558A>T
NM_001354507.1:c.558A>T
NM_001354508.1:c.558A>T
NM_001354509.1:c.558A>T
NM_001354511.1:c.558A>T
NM_001354512.1:c.558A>T
NM_001354513.1:c.558A>T
NM_001354523.1:c.558A>T
NM_001354526.1:c.558A>T
NM_001354538.1:c.618A>T
NM_001354539.1:c.558A>T
NM_001354540.1:c.558A>T
NM_001354541.1:c.558A>T
NM_001354542.1:c.558A>T
NM_001354543.1:c.558A>T
NM_001354544.1:c.558A>T
NM_001354545.1:c.618A>T
NM_001354546.1:c.441A>T
NM_001354547.1:c.558A>T
NM_001354548.1:c.558A>T
NM_001354549.1:c.558A>T
NM_001354550.1:c.361+3909A>T
NM_001354551.1:c.301+3909A>T
NM_130838.3:c.558A>T
NM_130839.4:c.618A>T
NR_146177.1:n.18393-20040T>A
NR_148916.1:n.1166A>T
NM_001354506.2:c.558A>T
NM_001354507.2:c.558A>T
NM_001354508.2:c.558A>T
NM_001354509.2:c.558A>T
NM_001354511.2:c.558A>T
NM_001354512.2:c.558A>T
NM_001354513.2:c.558A>T
NM_001354523.2:c.558A>T
NM_001354538.2:c.618A>T
NM_001354539.2:c.558A>T
NM_001354540.2:c.558A>T
NM_001354541.2:c.558A>T
NM_001354542.2:c.558A>T
NM_001354543.2:c.558A>T
NM_001354544.2:c.558A>T
NM_001354545.2:c.618A>T
NM_001354546.2:c.441A>T
NM_001354547.2:c.558A>T
NM_001354548.2:c.558A>T
NM_001354549.2:c.558A>T
NM_001354550.2:c.361+3909A>T
NM_001354551.2:c.301+3909A>T
NM_001374461.1:c.558A>T
NM_130838.4:c.558A>T
NR_148916.2:n.1134A>T
More

Benign

Met criteria codes 3
BA1 BP7 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the c.558A>T p.(Ala186=) variant in UBE3A (NM_130838.2) is 0.047% in the European (non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). In summary, the c.558A>T p.(Ala186=) variant in UBE3A is classified as Benign based on the ACMG/AMP criteria (BA1).
Met criteria codes
BA1
The allele frequency of the p.Ala186= variant in UBE3A is 0.047% in the European (non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions.
BP7
The silent p.Ala186= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide.
BP4
Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.